Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Sells $111,542.40 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 240 shares of the company’s stock in a transaction that occurred on Monday, August 12th. The stock was sold at an average price of $464.76, for a total transaction of $111,542.40. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,558,968.56. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Robert Desantis also recently made the following trade(s):

• On Friday, July 26th, Robert Desantis sold 1,413 shares of Intuitive Surgical stock. The stock was sold at an average price of $438.60, for a total transaction of $619,741.80.
• On Monday, July 29th, Robert Desantis sold 376 shares of Intuitive Surgical stock. The stock was sold at an average price of $446.60, for a total transaction of $167,921.60.
• On Monday, June 10th, Robert Desantis sold 239 shares of Intuitive Surgical stock. The stock was sold at an average price of $416.60, for a total transaction of $99,567.40.
• On Tuesday, May 28th, Robert Desantis sold 584 shares of Intuitive Surgical stock. The shares were sold at an average price of $404.41, for a total transaction of $236,175.44.

Intuitive Surgical Trading Up 0.8 %

NASDAQ ISRG traded up $3.69 during trading on Tuesday, hitting $469.22. The company had a trading volume of 469,556 shares, compared to its average volume of 1,558,284. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $470.49. The company has a market cap of $166.43 billion, a price-to-earnings ratio of 84.43, a price-to-earnings-growth ratio of 4.97 and a beta of 1.39. The company’s fifty day moving average is $438.40 and its 200-day moving average is $405.13.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, topping the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The business had revenue of $2.01 billion during the quarter, compared to analyst estimates of $1.97 billion. During the same period in the prior year, the business earned $1.18 EPS. The company’s revenue for the quarter was up 14.5% on a year-over-year basis. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on ISRG. Robert W. Baird upped their price objective on shares of Intuitive Surgical from $487.00 to $503.00 and gave the company an “outperform” rating in a research note on Friday, July 19th. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price objective for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Truist Financial upped their price objective on shares of Intuitive Surgical from $450.00 to $515.00 and gave the company a “buy” rating in a research note on Tuesday, July 16th. Citigroup upped their price objective on shares of Intuitive Surgical from $462.00 to $512.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Finally, The Goldman Sachs Group assumed coverage on shares of Intuitive Surgical in a research note on Thursday, May 30th. They issued a “buy” rating and a $500.00 price objective for the company. Six equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $442.30.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ISRG. Norges Bank bought a new stake in Intuitive Surgical during the 4th quarter valued at about $1,313,238,000. Capital Research Global Investors bought a new stake in Intuitive Surgical during the 1st quarter valued at about $374,390,000. Assenagon Asset Management S.A. increased its stake in Intuitive Surgical by 111.7% during the 1st quarter. Assenagon Asset Management S.A. now owns 1,285,565 shares of the medical equipment provider’s stock valued at $513,056,000 after purchasing an additional 678,375 shares in the last quarter. Coatue Management LLC increased its stake in Intuitive Surgical by 65.7% during the 4th quarter. Coatue Management LLC now owns 1,301,595 shares of the medical equipment provider’s stock valued at $439,106,000 after purchasing an additional 516,054 shares in the last quarter. Finally, Vanguard Group Inc. increased its stake in Intuitive Surgical by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock valued at $12,319,358,000 after purchasing an additional 493,126 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.